International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1703742

1703742PublishedVol 6 · Issue 3

Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form

Yogita Shinde Kalpana Patankar-Jain

Subject area: Science,Engineering and Technology  ·  Area of research: Analytical Chemistry

Abstract

A reverse phase high performance liquid chromatographic technique for validating 5-methyl-N-[2-(morpholin-4-yl)quinolin-3-yl]methyl-1,3-thiazol-2-amine (MMQMTA) in its original form has been developed. A HYPERSIL (250 x 4.6 mm, 5 m) ID column was used for the chromatography, and the mobile phase was a 60:40 mixture of methanol and ammonium acetate with a flow rate of 1.0 ml/min. The detection wavelength was 235 nm. MMQMTA had a retention time of 6.812 min. The approach yields linearity responses at concentrations of 4?24 mg/ml of MMQMTA. MMQMTA has a detection limit of 0.021 g/ml and an area of 2.61. Area 6.812 and 0.05 g/ml were reported as the MMQMTA limits of quantification, and the MMQMTA recovery rate was determined to be 99.98%. The technique is helpful for ensuring and monitoring the quality of pharmaceutical and bulk formulations.

Keywords

5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine, MMQMTA, RP-HPLC, validation.

How to cite this paper

Yogita Shinde, Kalpana Patankar-Jain "Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form" Iconic Research And Engineering Journals, vol. 6, no. 3, Sep. 2022
Yogita Shinde, Kalpana Patankar-Jain (2022). Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form. Iconic Research And Engineering Journals, 6(3).
Yogita Shinde, Kalpana Patankar-Jain "Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form" Iconic Research And Engineering Journals, vol. 6, no. 3, Sep. 2022.
@article{1703742,
      author = {Yogita Shinde, Kalpana Patankar-Jain},
      title = {Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {6},
      number = {3},
      pages = {106-111},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1703742.pdf},
      abstract = {A reverse phase high performance liquid chromatographic technique for validating 5-methyl-N-[2-(morpholin-4-yl)quinolin-3-yl]methyl-1,3-thiazol-2-amine (MMQMTA) in its original form has been developed. A HYPERSIL (250 x 4.6 mm, 5 m) ID column was used for the chromatography, and the mobile phase was a 60:40 mixture of methanol and ammonium acetate with a flow rate of 1.0 ml/min. The detection wavelength was 235 nm. MMQMTA had a retention time of 6.812 min. The approach yields linearity responses at concentrations of 4?24 mg/ml of MMQMTA. MMQMTA has a detection limit of 0.021 g/ml and an area of 2.61. Area 6.812 and 0.05 g/ml were reported as the MMQMTA limits of quantification, and the MMQMTA recovery rate was determined to be 99.98%. The technique is helpful for ensuring and monitoring the quality of pharmaceutical and bulk formulations.},
      keywords = {5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine, MMQMTA, RP-HPLC, validation.},
      month = {September},
  }